Rapid Micro Biosystems (RPID) Stock: Buy, Sell, or Hold?
RPID - Rapid Micro Biosystems, Inc. Class A Common Stock
$0.82
0.04 (5.77%)
▲
5d:
-0.13%
30d:
-28.4%
90d:
-58.98%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 06, 2026
14d
Get Alerted When RPID Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RPID shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RPID shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RPID is currently trading at $0.82, which is considered oversold relative to its 30-day fair value range of $0.84 to $1.11.
Technical Outlook: Technically, RPID is in a strong downtrend. Immediate support is located at $0.76, while resistance sits at $0.92. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: RPID scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.75 (+604.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RPID is in a strong downtrend. Immediate support is located at $0.76, while resistance sits at $0.92. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: RPID scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.75 (+604.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.84 -
$1.11
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 604.5% below Wall St target ($5.75)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.84 -
$1.11
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.76
Resistance Level
$0.92
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.14
Wall Street Target
$5.75
(+604.5%)
Revenue Growth (YoY)
10.9%
Profit Margin
-145.6%
Share & Embed Analysis
Last updated: October 22, 2026 5:55 AM ET
Data refreshes hourly during market hours. Next update: 6:55 AM
Data refreshes hourly during market hours. Next update: 6:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPID showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
